Literature DB >> 25544472

Factorial validity, measurement equivalence and cognitive performance of the Cambridge Neuropsychological Test Automated Battery (CANTAB) between patients with first-episode psychosis and healthy volunteers.

L Haring1, R Mõttus2, K Koch1, M Trei3, E Maron1.   

Abstract

BACKGROUND: The purpose of this study was to use selected Cambridge Neuropsychological Test Automated Battery (CANTAB) tests to examine the dimensional structure of cognitive dysfunction in first episode of psychosis (FEP) patients compared with cognition in healthy subjects.
METHOD: A total of 109 FEP patients and 96 healthy volunteers were administered eight CANTAB tests of cognitive function. Principal components analysis (PCA) was used to estimate dimensionality within the test results. The dimensions identified by the PCA were assumed to reflect underlying cognitive traits. The plausibility of latent factor models was estimated using confirmatory factor analysis (CFA). Multi-group CFA (MGCFA) was used to test for measurement invariance of factors between groups. The nature and severity of cognitive deficits amongst patients as opposed to controls were evaluated using a general linear model.
RESULTS: Amongst subjects PCA identified two underlying cognitive traits: (i) a broad cognitive domain; (ii) attention/memory and executive function domains. Corresponding CFA models were built that fitted data well for both FEP patients and healthy volunteers. As in MGCFA latent variables appeared differently defined in patient and control groups, differences had to be ascribed using subtest scores rather than their aggregates. At subtest score level the patients performed significantly worse than healthy subjects in all comparisons (p < 0.001).
CONCLUSIONS: Results of this study demonstrate that the structure of underlying cognitive abilities as measured by a selection of CANTAB tests is not the same for healthy individuals and FEP patients, with patients displaying widespread cognitive impairment.

Entities:  

Keywords:  CANTAB; cognitive function; first-episode psychosis; measurement invariance

Mesh:

Year:  2014        PMID: 25544472     DOI: 10.1017/S0033291714003018

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  11 in total

1.  The unity and diversity of executive functions: A systematic review and re-analysis of latent variable studies.

Authors:  Justin E Karr; Corson N Areshenkoff; Philippe Rast; Scott M Hofer; Grant L Iverson; Mauricio A Garcia-Barrera
Journal:  Psychol Bull       Date:  2018-08-06       Impact factor: 17.737

2.  Comparing the effects of subchronic phencyclidine and medial prefrontal cortex dysfunction on cognitive tests relevant to schizophrenia.

Authors:  K A L McAllister; A C Mar; D E Theobald; L M Saksida; T J Bussey
Journal:  Psychopharmacology (Berl)       Date:  2015-07-21       Impact factor: 4.530

3.  A Computerized Assessment of Verbal and Visuospatial Memory (Dys)functions in Patients with Rheumatoid Arthritis.

Authors:  Cristian Vasile Petra; Laura Visu-Petra; Monica Buta; Maria Magdalena Tămaș; Oana Benga; Simona Rednic
Journal:  Psychol Res Behav Manag       Date:  2020-08-04

4.  Patients with Darier Disease Exhibit Cognitive Impairment while Patients with Hailey-Hailey Disease Do Not: An Experimental, Matched Case-control Study.

Authors:  Philip Curman; Johanna Bern; Linnea Sand; Martin Cederlöf; Etty Bachar-Wikström; Jakob D Wikström
Journal:  Acta Derm Venereol       Date:  2021-06-22       Impact factor: 3.875

5.  Correlation of social cognition and neurocognition on psychotic outcome: a naturalistic follow-up study of subjects with attenuated psychosis syndrome.

Authors:  TianHong Zhang; HuiRu Cui; YingYing Tang; LiHua Xu; HuiJun Li; YanYan Wei; XiaoHua Liu; Annabelle Chow; ChunBo Li; KaiDa Jiang; ZePing Xiao; JiJun Wang
Journal:  Sci Rep       Date:  2016-10-10       Impact factor: 4.379

6.  The Association between Obesity and Cognitive Function in Otherwise Healthy Premenopausal Arab Women.

Authors:  Abdulaziz Farooq; Ann-Marie Gibson; John J Reilly; Nadia Gaoua
Journal:  J Obes       Date:  2018-03-08

7.  Relationship between muscarinic M1 receptor binding and cognition in medication-free subjects with psychosis.

Authors:  Geor Bakker; Claudia Vingerhoets; Daphne Boucherie; Matthan Caan; Oswald Bloemen; Jos Eersels; Jan Booij; Thérèse van Amelsvoort
Journal:  Neuroimage Clin       Date:  2018-03-03       Impact factor: 4.881

8.  Onset and transition of and recovery from adverse development: Study methodology.

Authors:  Johanna T W Wigman; Gerdina H M Pijnenborg; Richard Bruggeman; Maarten Vos; Anita Wessels; Inez Oosterholt; Maaike Nauta; Renee Stelwagen; Lana Otto; Anniek Wester; Lex Wunderink; Esther Sportel; Nynke Boonstra
Journal:  Early Interv Psychiatry       Date:  2019-11-05       Impact factor: 2.732

9.  The validation of a new online cognitive assessment tool: The MyCognition Quotient.

Authors:  Anna C Domen; Sjors C F van de Weijer; Monique W Jaspers; Damiaan Denys; Dorien H Nieman
Journal:  Int J Methods Psychiatr Res       Date:  2019-02-13       Impact factor: 4.035

10.  Distinct Functional Connectivity Patterns Are Associated With Social and Cognitive Lifestyle Factors: Pathways to Cognitive Reserve.

Authors:  Jessica I Fleck; Molly Arnold; Benjamin Dykstra; Katharine Casario; Elizabeth Douglas; Otto Morris
Journal:  Front Aging Neurosci       Date:  2019-11-13       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.